n-[(oxolan-2-yl)methyl]morpholine-4-carboxamide, 97%, 500mg

(S)-4-[3-(2-Dimethylamino-ethyl)-1H-indol-5-ylmethyl]-oxazolidin-2-one, 97.0%, 5g

2-Chloro-7-methylsulfanyl-quinoline-3-carbaldehyde, 95.0%, 10g

2-(8-Fluoronaphthalen-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 100mg

(3-Bromo-5-methoxyphenyl)methanol, 95.0%, 10g

2-Cyano-5-(trifluoromethyl)pyridine, 98.0%, 25g

4-Ethyl-4-methoxy-piperidine;hydrochloride, 95%, 250mg

N-iso-Propyl 4-fluoro-2-nitroaniline, 1g

7-BROMO-4-CHLORO-6-NITROQUINAZOLINE, 95.0%, 1g

4'-(trans-4-propylcyclohexyl)-[1,1'-biphenyl]-4-carbonitrile, 97.0%, 1g

6-Chlorobenzo[d]thiazole, 95.0%, 5g

ROTI®Sep 1086 mouse, 100 ml

4-Bromo-N1,3-dimethylbenzene-1,2-diamine, 98%, 500mg